Pulmonary manifestations of intentionally released chemical and biological agents

Clinics in Chest Medicine

Volumn 23, Issue 4, 2002, Pages 777-794

  Bogucki, Sandy ^a,b,c   Weir, Scott ^a,d,e  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b New Haven Police Department   (United States)

^c Branford Fire Department   (United States)

^d Hamden Fire Department   (United States)

^e Massey Building   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL AGENT;

CHEMICAL ANALYSIS; CHEMICAL INJURY; COMMUNITY CARE; HUMAN; LUNG DISEASE; OUTCOMES RESEARCH; POPULATION RISK; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURVIVAL; UNITED STATES;

BIOLOGICAL WARFARE; BIOTERRORISM; CHEMICAL WARFARE; HUMANS; INHALATION EXPOSURE; RESPIRATORY TRACT DISEASES; RISK;

EID: 0036956279     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(02)00027-8     Document Type: Review

References (63)

1. Geberding JL, Hughes JM, Koplan JP. Bioterrorism preparedness and response: Clinicians and public health agencies as essential partners. JAMA 2002;287:898-900.
2. Pavlin JA. Epidemiology of bioterrorism. Emerg Infect Dis 1999;5:528-30.
3. Rotz LD, Khan AS, Lillibridge SR, et al. Public health assessment of potential biological terrorism agents. Emerg Infect Dis 2002;8:225-30.
4. Centers for Disease Control and Prevention. Fatal human plague. MMWR 1997;278:380-7.
5. Campbell GL, Hughes JM. Plague in India: A new warning from an old nemesis. Ann Int Med 1995;122:151-3.
6. Franz DR, Jahrling PB, Friedlander AM, et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997;278:399-411.
7. Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biological weapon: Medical and public health management. JAMA 2000;283:2281-90.
8. McGovern TW, Friedlander AM. Plague. In: Zajtchuk R, Bellamy RF, editors. Textbook of Military Medicine. Part 1. Warfare, Weaponry, and the Casualty. Medical Aspects of Chemical and Biological Warfare. Falls Church (VA): Office of the Surgeon General; 1997. p. 479-502.
9. Relman DA, Olson JE. Bioterrorism preparedness: What practitioners need to know. Infect Med 2001;18:497-514.
10. Miller JM. Agents of bioterrorism. Infect Dis Clin N Am 2001;15:1127-56.
11. Sawyer WD, Jemski JV, Hogge AL, et al. Effect of aerosol age on the infectivity of airborne Pasteurella tularensis for Macaca mulatta and man. J Bacteriol 1966;91:2180-4.
12. Homick RB. Tularemia. In: Evans AS, Brachman PS, editors. Bacterial Infections of Humans: Epidemiology and Control. 3rd Edition. New York: Plenum Medical Books; 1998. p. 823-37.
13. Alibek K. Biohazard. New York: Random House; 1999.
14. Reintjes R, Dedushaj I, Gjini A, et al. Tularemia outbreak investigation in Kosovo: Case control and environmental studies. Emerg Infect Dis 2002;8:69-73.
15. Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon: Medical and public health management. JAMA 2001;285:2763-73.
16. McCrumb FR. Aerosol infection of man with Pasteurella tularensis. Bacteriol Rev 1961;25:262-7.
17. Teutsch SM, Martone WJ, Brink EW, et al. Pneumonic tularemia on Martha's Vineyard. N Engl J Med 1979;301:826-8.
18. Feldman KA, Enscore RE, Lathrop SL, et al. An outbreak of primary pneumonic tularemia on Martha's Vineyard. N Engl J Med 2001;345:1601-6.
19. Overholt EL, Tiggertt WD, Kadull PS, et al. An analysis of 42 cases of laboratory-acquired tularemia: Treatment with broad spectrum antibiotic. Am J Med 1961;30:785-806.
20. Sawyer WD, Dangerfield HG, Hogge AL, et al. Antibiotic prophylaxis and therapy of airborne tularemia. Bact Rev 1966;30:542-8.
21. Dixon TC, Meselson M, Guillemin J, et al. Anthrax. N Engl J Med 1999;341:815-26.
22. Kortepeter MG, Parker GW. Potential biological weapons threats. Emerg Infect Dis 1999;5:523-7.
23. Inglesby TV, O'Toole T, Henderson DA, et al. Anthrax as a biological weapon, 2002: Updated recommendations for management. JAMA 2002;287:2236-52.
24. Meselson M, Guillemin J, Hugh-Jones M, et al. The Sverdlovsk anthrax outbreak of 1979. Science 1994;266:1202-8.
25. Swartz MN. Recognition and management of anthrax an update. N Engl J Med 2001;345:1621-6.
26. Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. MMWR 2001;50:941-8.
27. Bell DM, Kozarsky PE, Stephens DS. Clinical issues in the prophylaxis, diagnosis and treatment of anthrax. Emerg Infect Dis 2002;8:222-4.
28. Clifford NJ, Nies AS. Organophosphate poisoning from wearing a laundered uniform previously contaminated with parathion. JAMA 1989;262(21):3035-6.
29. Davis KG, Aspera G. Exposure to liquid sulfur mustard. Ann Emerg Med 2001;37(6):653-6.
30. Earls JP, Cerva D, Berman E, et al. Inhalational anthrax after bioterrorism exposure: Spectrum of imaging findings in two surviving patients. Radiology 2002;222:305-12.
31. Inglesby TV, Henderson DA, Bartlett JG, et al. Anthrax as a biological weapon. JAMA 1999;281:1735-45.
32. Jernigan JA, Stephens DS, Ashford DA, et al. Bioterrorism-related inhalational anthrax: The first 10 cases reported in the United States. Emerg Infect Dis 2001;7:933-44.
33. Kadivar H, Adams SC. Treatment of chemical and biological warfare injuries: Insights derived from the 1984 Iraqi attacks on Manjoon Island. Military Med 1991;156(4):171-7.
34. Kales SN, Polyhronopoulos GN, Castro MJ, et al. Injuries caused by hazardous materials agents. Ann Emerg Med 1997;30(5):598-603.
35. Karalliedde L, Wheeler H, Maclehose R, et al. Possible immediate and long-term health effects following exposure to chemical warfare agents. Public Health 2000;114:238-48.
36. Karsenty E, Shemer J, Alshech I, et al. Medical aspects of the Iraqi missile attacks on Israel. Israel J Med Sci 1991;27(11-12):603-7.
37. Macintyre AG, Christopher GW, Eitzen Jr E, et al. Weapons of mass destruction events with contaminated casualties: Effective planning for health care facilities. JAMA 2000;283(2):242-9.
38. Morita H, Yanigasawa N, Nakajimi T, et al. Sarin poisoning in Matsumoto, Japan. Lancet 1995;346(8970):290-3.
39. Nozaki H, Hori S, Shinozawa Y, et al. Secondary exposure of medical staff to Sarin vapor in the emergency room. Intensive Care Med 1995;21:1032-5.
40. Okudera H, Morita H, Iwashita T, et al. Unexpected nerve gas exposure in the city of Matsumoto: Report of rescue activity in the first Sarin gas terrorism. Am J Emerg Med 1997;15:527-8.
41. Okumura T, Takasu N, Ishimatsu S, et al. Report of 640 victims of the Tokyo subway sarin attack. Ann Emerg Med 1996;28(2):129-35.
42. Okumura T, Suzuki K, Fukada A, et al. The Tokyo subway sarin attack: Disaster management. Part 1: Community emergency response. Ann Emerg Med 1998;5(6):613-7.
43. Okumura T, Suzuki K, Fukada A, et al. The Tokyo subway sarin attack: Disaster management. Part 2: Hospital response. Ann Emerg Med 1998;5(6):618-24.
44. Rapid Contingency Plans for Responding to Victims of a Chemical Attack: Handling Casualties and Decontamination. Washington (DC): Office of Public Health and Environmental Hazards, Department of Veterans Affairs; October 2001.
45. Sidell FR. What to do in case of an unthinkable chemical warfare attack or accident. Postgrad Med 1990;88(7):70-84.
46. Sidell FR. Nerve agents. In: Zajtchuk R, Bellamy RF, editors. Textbook of Military Medicine. Part I: Medical Aspects of Chemical and Biological Warfare. Falls Church (VA): Office of the Surgeon General, Dept of the Army; 1997. p. 129-79.
47. Sidell FR, Hurst CG. Long-term health effects of nerve agent and mustard. In: Zajtchuk R, Bellamy RF, editors. Textbook of Military Medicine. Part I: Medical Aspects of Chemical and Biological Warfare. Falls Church (VA): Office of the Surgeon General, Dept of the Army; 1997. p. 229-46.
48. Sidell FR, Urbanetti JS, Smith WJ, et al Vesicants. In: Zajtchuk R, Bellamy RF, editors. Textbook of Military Medicine. Part I: Medical Aspects of Chemical and Biological Warfare. Falls Church (VA): Office of the Surgeon General, Dept of the Army; 1997. p. 197-228.
49. Smith WJ, Dunn MA. Medical defense against blistering chemical warfare agents. Arch Dermatol 1991;127:1207-13.
50. Solberg Y, Alcalay M, Belkin M. Ocular injury by mustard gas. Surv Ophthalmol 1997;41(6):461-6.
51. Binder S. Deaths, injuries and evacuations from acute hazardous materials releases. Am J Public Health 1989;79(8):1042-4.
52. Ballard T, Pate J, Ackerman G, et al. Chronology of Aum Shinrikyo's CBW Activities. Monterey Institute of International Studies. Available at http://cns.miis.edu. Accessed March 15, 2001.
53. Agency for Toxic Substances and Disease Registry (ATSDR). Managing Hazardous Material Incidents (MHMI). Volume 1: Emergency Medical Services: A Planning Guide for the Management of Contaminated Patients. Atlanta: U.S. Department of Health and Human Services, Public Health Service; 2001.
54. Agency for Toxic Substances and Disease Registry (ATSDR). Managing Hazardous Material Incidents (MHMI). Volume 2: Hospital Emergency Departments: A Planning Guide for the Management of Contaminated Patients. Atlanta: U.S. Department of Health and Human Services, Public Health Service; 2001.
55. Agency for Toxic Substances and Disease Registry (ATSDR). Managing Hazardous Material Incidents (MHMI). Volume 3: Medical Management Guidelines (MMGs) for Acute Chemical Exposures. Atlanta: U.S. Department of Health and Human Services, Public Health Service; GA, 2001.
56. Thanabalasongham T, Beckett MW, Murray V. Hospital response to a chemical incident: Report on casualties of an ethyldichlorosilan spill. BMJ 1991;302:101-2.
57. Agency for Toxic Substance and Disease Registry (ATSDR). Medical Management Guidelines for Acute Chemical Exposures. Atlanta: U.S. Department of Human Services, Public Health Service; 1992.
58. Almog S, Winkler E, Amitai Y, et al. Acute pyridostigmine: A report of nine cases. Israel J Med Sci 1991;27(11-12):659-63.
59. Barach P, Rivkind A, Israeli A, et al. Emergency preparedness and response during the Gulf War. Ann Emerg Med 1998;32(2):224-33.
60. Anonymous. Prevention and treatment of injury from chemical warfare agents. The Medical Letter 2002;44(1121):1-4.
61. US Army Medical Research Institute of Chemical Defense (USAMRICD). Medical Management of Chemical Casualties Handbook. 3rd Edition. Fort Detrick, Frederick (MD): Chemical Casualty Care Division; July 2000.
62. Urbanetti JS. Toxic inhalation injury. In: Zajtchuk R, Bellamy RF, editors. Textbook of Military Medicine. Part I: Medical Aspects of Chemical and Biological Warfare. Falls Church (VA): Office of the Surgeon General, Dept of the Army; 1997. p. 247-70.
63. Baskin SI, Brewer TG. Cyanide poisoning. In: Zajtchuk R, Bellamy RF, editors. Textbook of military medicine. Part I: Medical aspects of chemical and biological warfare. Falls Church (VA): Office of the Surgeon General, Dept of the Army; 1997. p. 271-86.